← Eichor
Study identifier: NCT04604730 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Role of Protective Stoma After Primary Anastomosis for Generalized Peritonitis Due to Perforated Diverticulitis

Condition: Peritonitis  ·  Sponsor: University Hospital, Rouen

PhaseNA
Planned participants204
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is designed to be a multicentre, prospective, comparative, randomised trial, evaluating the efficacy of two surgical strategies for the treatment of generalised peritonitis due to perforated diverticulitis. Results will be analysed according to an intention to treat principle (after selection and patient consent). Immediately before surgery, the patient will be randomly assigned to sigmoidectomy with primary anastomosis or to sigmoidectomy with primary anastomosis and diverting stoma. Sigmoidectomy will be performed through a midline laparotomy or laparoscopically according to the standard technique. In the control arm, a protective stoma will be performed at the end of surgery. A stoma reversal operation will be performed at least 3 months after the first operation and after performing a cologram by water soluble contrast between 4 and 8 weeks to check for the absence of fistula or stenosis at the level of the anastomosis. Stoma reversal will be performed with a trephine incision. Post-stoma closure follow-ups will be planned and all morbidity/mortality will be recorded. All patients will be examined at 6, 12, and 24 weeks after the initial surgery, in the surgical department where they were operated; a final study visit will be carried out 12 months (evaluation of primary endpoint) after surgery. The parameters explored at medical examinations will be: • Occurrence of complications • Quality of life assessment

This description comes directly from the study's public registry record.

Talk to the study team

Valérie BRIDOUX, Pr  ·  02 32 88 81 42  ·  valerie.bridoux@chu-rouen.fr

Always discuss trial participation with your own doctor first.

Locations (20)

CHR BeauvaisBeauvais, Beauvais, FranceNot Yet Recruiting
CHU AmiensAmiens, FranceRecruiting
CH BeauvaisBeauvais, FranceNot Yet Recruiting
CHU BesançonBesançon, FranceNot Yet Recruiting
APHP AvicenneBobigny, FranceNot Yet Recruiting
CHU BrestBrest, FranceRecruiting
CHU CaenCaen, FranceNot Yet Recruiting
CHU Clermont FerrandClermont-Ferrand, FranceNot Yet Recruiting
APHP Henri MondorCréteil, FranceNot Yet Recruiting
CHU GrenobleGrenoble, FranceNot Yet Recruiting
CHU LimogesLimoges, FranceNot Yet Recruiting
CHU LyonLyon, FranceNot Yet Recruiting

+ 8 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04604730